Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease

Контроль липидов для профилактики атеросклеротических сердечно-сосудистых заболеваний
Erin D. Michos, John William McEvoy, Roger Scott Blumenthal
2019-10-16
SCID:  54.1/a8ztdwep Discuss with AI
atherosclerotic cardiovascular diseasecardiovascular risklipid managementserum cholesterolstatins
Abstract (AI)
Management of serum cholesterol level is a central objective in preventing cardiovascular events. Current guidelines recommend calculation of cardiovascular risk, with treatment decisions based on these data and clinician–patient discussion of risk. Statins remain the first line of pharmacotherapy.
Key Findings
1
Current guidelines recommend basing lipid-treatment decisions on calculated cardiovascular risk and clinician–patient discussions.
2
Serum cholesterol management is a central strategy for preventing atherosclerotic cardiovascular events.
3
Statins remain the first-line pharmacological treatment for lipid management and cardiovascular prevention.
Research Object

serum cholesterol management for prevention of atherosclerotic cardiovascular disease

Research Subject

cardiovascular risk assessment and lipid-lowering treatment decisions, including the role of statins in preventing cardiovascular events

Publication Details
Publication Date
2019-10-16
Journal
Publisher
ISSN
Cited by
351
Access Type
Author Information
Authors
Erin D. Michos
John William McEvoy
Roger Scott Blumenthal
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%